Ms Susan T Evers, ARNP in Badger, IA - Nurse Practitioner

Ms Susan T Evers, ARNP is a Nurse Practitioner - Women's Health based in Badger, Iowa. Ms Susan T Evers is licensed to practice in Iowa (license number F-051368) and her current practice location is 1005 National Ave, Badger, Iowa. She can be reached at her office (for appointments etc.) via phone at (515) 545-4243.

NPI number for Ms Susan T Evers is 1972593689 and her current mailing address is 1005 National Ave, Badger, Iowa. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1972593689.

Contact Information

	Ms Susan T Evers, ARNP
	1005 National Ave, Badger, IA 50516-7511
	(515) 545-4243
	Not Available

Provider's Profile

Full Name	Ms Susan T Evers
Gender	Female
Speciality	Nurse Practitioner - Women's Health
Location	1005 National Ave, Badger, Iowa
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1972593689
Provider Enumeration Date: 10/24/2005
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Ms Susan T Evers such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1972593689	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363LW0102X	Nurse Practitioner - Women's Health	F-051368 (Iowa)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Susan T Evers is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ms Susan T Evers, ARNP 1005 National Ave, Badger, IA 50516-7511 Ph: (515) 545-4243	Ms Susan T Evers, ARNP 1005 National Ave, Badger, IA 50516-7511 Ph: (515) 545-4243

News Archive

Spectrum initiates enrollment in RenaZorb Phase 1 trial in healthy volunteers

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, today announced the initiation of patient enrollment in a Phase 1 clinical trial evaluating the safety and tolerability of RenaZorb in healthy volunteers.

CTE can be diagnosed by neuropathological examination of brain tissue

For the first time, CTE has been confirmed as a unique disease that can be definitively diagnosed by neuropathological examination of brain tissue. A consensus panel of expert neuropathologists concluded that CTE has a pathognomonic signature in the brain, an advance that represents a milestone for CTE research and lays the foundation for future studies defining the clinical symptoms, genetic risk factors and therapeutic strategies for CTE.

Concussion during adolescence may be more common than previously thought

Sustaining a concussion during adolescence may be more common than previous estimates, according to researchers presenting their study at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Colorado Springs, CO today.

Modified measure quickly and effectively gauges intraventricular hemorrhage

Researchers have modified the Graeb score to produce a reliable, simple, quick, and clinically meaningful approximation of intraventricular hemorrhage volume.

Ms Susan T Evers, ARNP - Nurse Practitioner in Badger, IA